Form 10-K405 - Annual report [Sections 13 and 15(d), S-K Item 405]:
SEC Accession No. 0000950144-01-004269
Filing Date
2001-03-29
Accepted
2001-03-29 00:00:00
Documents
9
Period of Report
2000-12-31

Document Format Files

Seq Description Document Type Size
1 CELERIS CORPORATION g67917e10-k405.txt 10-K405 133259
2 EMPLOYMENT AGREEMENT g67917ex10-10.txt EX-10.10 25023
3 CHANGE IN CONTROL SEVERANCE AGREEMENT g67917ex10-11.txt EX-10.11 16443
4 CONSENT OF ARTHUR ANDERSEN LLP g67917ex23-1.txt EX-23.1 524
5 PRESS RELEASE DATED 11/17/00 g67917ex99-1.txt EX-99.1 5178
6 PRESS RELEASE DATED 1/18/01 g67917ex99-2.txt EX-99.2 2874
7 PRESS RELEASE DATED 2/7/01 g67917ex99-3.txt EX-99.3 13613
8 PRESS RELEASE DATED 3/6/01 g67917ex99-4.txt EX-99.4 4182
9 PRESS RELEASE DATED 3/13/01 g67917ex99-5.txt EX-99.5 3568
  Complete submission text file 0000950144-01-004269.txt   207339
Mailing Address 1801 WEST END AVENUE SUITE 750 NASHVILLE TN 37203
Business Address 1801 WEST END AVENUE SUITE 750 NASHVILLE TN 37203 6153410223
CELERIS CORP (Filer) CIK: 0000946994 (see all company filings)

EIN.: 411545493 | State of Incorp.: MN | Fiscal Year End: 1231
Type: 10-K405 | Act: 34 | File No.: 000-26390 | Film No.: 1585033
SIC: 8731 Services-Commercial Physical & Biological Research